A new electroanalytical method for detecting methylamphetamine as a stimulant drug in human urine has been proposed for forensic purposes. Although methylamphetamine itself has no remarkable voltammetric waves at any electrode in various electrolytes, we have found that the copper complex of methylamphetamine obtained by the method of Feigl showed a well-defined peak at -0.56 V (vs. SCE) at a mercury electrode by differential pulse polarography (DPP) in an aqueous ethanol solution containing 0.25 M ammonium acetate. The peak height was linear as a function of the methylamphetamine concentration in the original test solutions in the region of at least 0 -50 µg/ml. The concentrations of methylamphetamine determined by the present method for eight abusers' urine samples were in excellent agreement with those obtained by the conventional methods (GC-MS analysis) so far used. The proposed method is rather simple in procedure, rapid and selective with a satisfactory detection limit (<0.125 mg/ml) for analysis of methylamphetamine, and would also be applicable for field use.
Methylamphetamine (or methanephetamine, methedrine, 1-phenyl-2-aminomethylpropane, see Fig.  1 ), which was found in 1893 in the process of extracting ephedrine from ephedra 1 , is now well-known as a typical stimulant drug. An increase in number of abusers of this drug in recent years is a serious social problem not only in Japan but also in some other countries, and this drug problem is often related to various atrocious crimes. Among the drugs in Japan, stimulants are more than 70%. 2 To detect methylamphetamine in urine, a few conventional methods based on the coloring test (e.g., by the reaction with a secondary amine to give a color in yellow or brown) have so far been used for screening the samples. 3 However, these methods have sometimes lead to misjudging, because of the similarity in the generated color to those of urine samples. Furthermore, these conventional methods usually require complicated operational procedures of at least five steps, and have unsatisfactory detection limit for practical use for the sample volume of at most 10 ml, which is usually available for such an inspection. Thus, some difficulties arise in judging within a short time whether the drug is contained or not in urine samples.
Recently, an antigen-antibody immunoassay of methylamphetamine has been reported using polyclonal or monoclonal antibody against methylamphetamine, such as enzyme linked immunosorbent assay 4 , radio immunoassay 5 and latex agglutination assay. 6 However, although the selectivity and the detection limit have been improved in these methods, these are rather time-consuming methods and require several complicated operational steps for analysis. Therefore, a simple and easy technique has been urgently desired for the detection of methylamphetamine to help the activities of the Drug Enforcement Division in Japan and other countries. For the present purpose, the desirable technique for methylamphetamine analysis will be rapid, simple, and of high sensitivity in analysis and preferably be portable for possible field use.
Electrochemical method is a candidate for the present purpose, because it has such advantages that handy-size equipment is now commercially available. The technique is rather time-saving and quantitative and qualitative analyses with satisfactory sensitivity can be expected by selecting a mode of the technique, depending on the required detection limit. Electrochemical techniques may also be applicable to identify a wide variety of unlawful drugs such as morphine, codeine, narcotine, or heroin, because, for example, catalytic hydrogen waves can be seen for these drugs. pulse polarography (DPP) becomes a satisfactory technique when the copper complex of methylamphetamine is derived as an analyte from methylamphetamine.
Experimental

Reagents
Methylamphetamine and methoxyphenamine were obtained from Dai-nihon Seiyaku (Osaka) and Nihon Seibutsu Kagaku (Tokyo), respectively. Caffeine was from Torii Yakuhin (Tokyo) and methylephedrine was obtained as a cold medicine. Brij-35 (polyethylene glycol ether, from Wako) was used as a polarographic maximum suppresser. Other reagents used including pure water (Katayama Kagaku, HPLC grade) were of the highest analytical reagent grade.
Polarographic measurements
DPP voltammograms were usually obtained in the potential region from -0.2 to -0.9 V (vs. SCE) at a scan rate of 2 mV s -1 at 25˚C using a Yanaco P-1100 polarographic analyzer with a Graphtec X-Y recorder. Potentials were referred with respect to a saturated calomel electrode (SCE), and were monitored using an Iwatsu SC-7404 digital voltmeter. Pulse width, pulse interval and modulation amplitude used were 50 ms, 2 s and 50 mV, respectively. The reproducible mercury drops with the capillary constant (m 2/3 t 1/6 ) of 1.305 mg 2/3 s -1/2 with m=1.255 mg s -1 in the blank electrolyte solution at 25˚C and 0 V (vs. SCE) were used. The test solutions were prepared by diluting 1 ml acetone solution of the extracted copper complex from urine samples with 5 ml aqueous solution of 0.5 M ammonium acetate as a supporting electrolyte, and then with an ethanol solution containing 0.1% (in final concentration) detergent (Brij-35) as a maximum suppresser to make the total volume of 10 ml. Nitrogen gas (99.99%) was bubbled for 20 min to remove dissolved oxygen from the electrolyte through a pre-cell with a solution of the same composition as that of the test solution to eliminate any change in concentration of acetone and ethanol in the electrolyte by evaporation. During the measurements, nitrogen atmosphere was maintained over the solution.
Preparation of standard solutions of the copper complex
Standard solutions were prepared for methylephedrine, methoxyphenamine, caffeine and methylamphetamine (0, 10, 20, 40, 50 mg/ml) as follows. An aqueous solution (5 ml) of each drug was added to 5 ml of a 10 mg/ml copper sulfate solution and the mixture was made basic with 4 ml of a 28% ammonia solution. The blue solution obtained was then shaken with a ca. 5 ml solution of CS 2 and benzene (1:3 in volume) mixture. The reaction took place immediately for methylamphetamine and methoxyphenamine, and the benzene layer turned brown or yellow by the following reaction.
where N(R 1 )HR 2 is methylamphetamine or methoxyphenamine (see Fig. 1 ). After washing the benzene layer with pure water until all water-soluble substances had been completely removed, the benzene layer was separated to be evaporated to dryness. The residue thus obtained was dissolved in ethanol after two drops of acetone was added. These procedures can be carried out even in a test tube without using any special tools. The urine samples were also treated in the same manner.
Identification of the copper complex of methylamphetamine
To confirm the structure of the copper complex of methylamphetamine, the complex was separated and purified by thin-layer chromatography, which was particularly suitable to separate the complex. The product obtained by the Feigl method was dissolved in acetone and thin-layer chromatographed together with methylamphetamine for comparison. The silica gel plate was developed with a hexane-acetone (9:1) mixture and then dried at room temperature. The copper complex of methylamphetamine gave a single spot with the R f value of 0.30, while the R f value of methylamphetamine was 0.18. Methylamphetamine (but not the copper complex) turned to violet when the Simon reagent 8, 9 was spread over (Note that, unfortunately, the detection limit of methylamphetamine for this coloring test is at most 10 mg/ml or larger in solution 3 ). The spot of copper complex of methylamphetamine was extracted with acetone and evaporated to dryness. Then the complex was again dissolved in acetone. The isolated complex was analyzed by atomic absorption for copper (using a Perkin Elmer M-1100B spectrophotometer; 324.5 nm as an excitation line), GC-MS (using a HP-5890/5972 mass spectrometer) and FT-IR (using a Nicolet-710 266 ANALYTICAL SCIENCES APRIL 1998, VOL. 14 spectrophotometer) spectroscopies. The analytical results showed that the complex is that obtained by the Feigl method given by Eq. (1).
Results and Discussion
Polarographic measurements
The DPP voltammograms were recorded in aqueous ethanol solutions with various supporting electrolytes. When 0.25 M ammonium acetate, instead of 0.1 M tartaric acid which has been often used for copper complexes, was used as a supporting electrolyte, the DPP peak due to the copper complex of methylamphetamine gave the highest peak.
The logarithmic analysis of the conventional DC polarogram (-28±2 mV/dec.) showed that the reduction of the copper complex of methylamphetamine was reversible two-electron reaction. The half-wave potential shifted roughly (note that aqueous ethanol solutions were used) by -60 mV/apparent pH. Thus, the reaction can be given as:
DPP voltammograms showed the redox potential of this copper complex at -0.56 V (vs. SCE), which was independent of the concentration of copper complex of methylamphetamine (see Fig. 2 ). Since Cu(II) gave a reduction peak at -0.12 V (vs. SCE) under the same experimental conditions, the formation of the copper complex with methylamphetamine caused the negative shift in redox potential of Cu(II) by about 0.44 V due to the stabilization of Cu(II) by the coordinated sulfur atoms.
Preparation of the calibration curve
The calibration curve for methylamphetamine was prepared on the basis of DPP measurements by using standard solutions of the copper complex of methylamphetamine. The peak height of DPP voltammogram gave a straight line with the concentration of the complex at least up to 80 mg/ml, as shown in Fig. 3 .
Selectivity and detection limit
The selectivity of the present method for analysis of methylamphetamine was investigated in the presence of caffeine and methylephedrine which were usually contained in urine. Methylamphetamine easily forms the complex with copper ion in a basic ammonium solution (the solution turned brown or yellow), while no copper complex was formed with either caffeine or methylephedrine, and no other DPP voltammetric peak than the complex of methylamphetamine was observed in the potential range tested. On the other hand, methoxyphenamine, which is a secondary amine and contained in a certain cough medicine, gave the copper complex by the Feigl method (see Eq. (1)) as in the case of methylamphetamine. However, fortunately, the copper complex of methoxyphenamine showed the reduction DPP peak at -0.68 V (vs. SCE) and was easily distinguished from that of methylamphetamine (-0.56 V vs. SCE). No remarkable interference against the voltammogram was observed for all urine samples examined. These results suggest that the present method is applicable to the selective determination of methylamphetamine in urine. The detection limit for methylamphetamine by the present method was 0.1 and 0.125 mg/ml or less for pure and urine sample solutions, respective-267 ANALYTICAL SCIENCES APRIL 1998, VOL. 14 ly, for the S/N ratio of 4, which is more than satisfactory for the actual requirement for most forensic and clinical purposes.
DPP polarographic measurement of human urine samples
Eight samples of abusers' urine were analyzed by the presently proposed method. Although for quantitative analysis it was preferable to degas dissolved oxygen by bubbling with nitrogen gas into sample solutions, for simple qualitative screening of methylamphetamine it was not necessary to remove dissolved air from the test solutions, because oxygen was reduced in the present solution at -0.28 V and did not interfere so much the voltammogram of the copper complex. The half-wave potential observed, -0.56 V (vs. SCE), was the same for all urine samples as that of a pure authentic sample. The concentrations of methylamphetamine in urine obtained by DPP were in excellent agreement (with relative errors of utmost 10%) with the results by gas chromatography as one of conventional methods (see Table 1 ), where for both cases analyses were carried out after methylamphetamine in a sample was converted to the copper complex by the Feigl method.
Taking into account the following advantages, the presently proposed method is useful to determine methylamphetamine in urine samples as a routine primary screening for forensic and clinical purposes. The advantages of the present method would be: (1) simple technique for field use, (2) high-sensitivity (detection limit of less than 0.125 mg/ml) without any interference of caffeine and methylephedrine, (3) easy and rapid qualitative and quantitative analysis, and (4) small volume of urine sample (5 ml or less) for analysis.
Although at present use of solid electrodes gave less reproducible results with lower sensitivity than at a mercury electrode, efforts are now under way to improve the technique for more preferable field use.
